Moderna
CompanyUnited States
Moderna develops one asset, in human trials (intismeran autogene in melanoma). Mostly mrna; based in the United States.
- 1
- Asset
- Furthest stage
- Human trials
- 0
- Trials
- 1
- Signal
Pipeline
1Encodes individualized tumor neoantigens to stimulate tumor-specific T-cell immune responses.
Human trials, mRNA, melanoma, other cancers
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Signals1
- Similar companies6